Status:
NOT_YET_RECRUITING
BE.Amycon Biobank & Data Registry UZ Leuven
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Amyloidosis
AL Amyloidosis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this study is to collect and store human body material (HBM) of patients with amyloidosis in a biobank "BE.Amycon biobank" for future research and to collect clinical data of patients with...
Detailed Description
With the support of VIB (Vlaams Instituut voor Biotechnologie) Grand Challenges Program, this project aims to establish the BElgian AMYloidosis CONsortium (BE.AMYCON) by joining forces of VIB research...
Eligibility Criteria
Inclusion
- Provide consent and sign informed consent form
- Age 18 years or older
- Diagnosis of amyloidosis (suspected or confirmed, any subtypes)
- For the prospective sample collection only: newly diagnosed (any subtype) or at relapse (AL amyloidosis)
Exclusion
- Not willing to sign informed consent
- Not able to sign informed consent
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
505 Patients enrolled
Trial Details
Trial ID
NCT07172243
Start Date
September 1 2025
End Date
January 1 2030
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven Gasthuisberg
Leuven, Belgium, 3000